# Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents

> **NCT01443104** · NA · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 2119 (actual)

## Conditions studied

- Coronary Artery Disease
- Angina Pectoris
- Myocardial Infarction

## Interventions

- **DEVICE:** Sirolimus-eluting stent with a bioresorbable polymer (Orsiro)
- **DEVICE:** Everolimus-eluting stent with a durable polymer

## Key facts

- **NCT ID:** NCT01443104
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2014-06
- **Final completion:** 2018-06
- **Target enrollment:** 2119 (ACTUAL)
- **Last updated:** 2018-10-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01443104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01443104, "Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01443104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*